High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era

10.1200/JCO.2005.03.1674

10.1200/JCO.2005.04.503

10.1200/JCO.2008.16.0283

Bastion Y, 1997, J Clin Oncol, 15, 1587, 10.1200/JCO.1997.15.4.1587

10.1200/JCO.2006.09.3260

10.1182/asheducation-2009.1.532

10.1056/NEJMoa011795

10.1200/JCO.2005.05.1003

10.1182/blood-2005-01-0016

Al-Tourah AJ, 2007, Blood, 110

10.1016/j.bbmt.2010.11.003

2011, NCCN Clinical Practice Guidelines in Oncology version 2.2011

10.1046/j.1365-2141.2001.02705.x

10.1023/A:1008349427337

10.1053/bbmt.1999.v5.pm10465106

Ramadan KM, 2008, Blood, 112

10.1016/j.bbmt.2007.04.009

Williams CD, 2001, J Clin Oncol, 19, 727, 10.1200/JCO.2001.19.3.727

Friedberg JW, 2006, Haematologica, 91, 1453

Friedberg JW, 1999, J Clin Oncol, 17, 3128, 10.1200/JCO.1999.17.10.3128

10.1080/10428190903128652

10.1200/JCO.2010.28.1618

Tan D, 2007, Blood, 110

10.1182/asheducation-2005.1.329

10.1111/j.1365-2141.2010.08519.x

Schaefer-Cutillo J, 2007, Oncology (Williston Park), 21, 203

10.1200/JCO.2006.09.1215

10.1182/blood.V99.9.3158

10.3109/10428194.2010.497981

10.1200/JCO.2007.11.5477

10.1080/10428190802491714

10.1038/bmt.2008.220

Villa D, 2011, Ann Oncol, 22, 1